Smilagenin and its use
US7368137B2 · kind B2 · utility
0Cited by
8References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 9, 2007 |
| Grant date | May 6, 2008 |
| Priority date | — |
| Expiry date | Jan 9, 2027 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/944
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention discloses the use of a smilagenin in the treatment of cognitive dysfunction and similar conditions. Methods of treatment, and pharmaceutical compositions are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.